244 related articles for article (PubMed ID: 16505139)
21. Recombinant antigen delivery to dendritic cells as a way to improve vaccine design.
de Souza-Silva GA; Sulczewski FB; Boscardin SB
Exp Biol Med (Maywood); 2023 Oct; 248(19):1616-1623. PubMed ID: 37750021
[TBL] [Abstract][Full Text] [Related]
22. Heterologous DNA Prime- Subunit Protein Boost with Chikungunya Virus E2 Induces Neutralizing Antibodies and Cellular-Mediated Immunity.
Coirada FC; Fernandes ER; Mello LR; Schuch V; Soares Campos G; Braconi CT; Boscardin SB; Santoro Rosa D
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445695
[TBL] [Abstract][Full Text] [Related]
23. New tools for immunologists: models of lymph node function from cells to tissues.
Ozulumba T; Montalbine AN; Ortiz-Cárdenas JE; Pompano RR
Front Immunol; 2023; 14():1183286. PubMed ID: 37234163
[TBL] [Abstract][Full Text] [Related]
24. Targeting the P10 Peptide in Maturing Dendritic Cells via the DEC205 Receptor In Vivo: A New Therapeutic Strategy against Paracoccidioidomycosis.
Santos SS; Rampazo E; Taborda CP; Nosanchuk JD; Boscardin SB; Almeida SR
J Fungi (Basel); 2023 May; 9(5):. PubMed ID: 37233259
[TBL] [Abstract][Full Text] [Related]
25. STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor.
Sulczewski FB; Martino LA; Salles D; Yamamoto MM; Rosa DS; Boscardin SB
Front Immunol; 2022; 13():1006996. PubMed ID: 36330518
[TBL] [Abstract][Full Text] [Related]
26. Immunization with CSP and a RIG-I Agonist is Effective in Inducing a Functional and Protective Humoral Response Against
Teixeira AR; Pérez-Cabezas B; Costa DM; Sá M; Golba S; Sefiane-Djemaoune H; Ribeiro J; Kaneko I; Iwanaga S; Yuda M; Tsuji M; Boscardin SB; Amino R; Cordeiro-da-Silva A; Tavares J
Front Immunol; 2022; 13():868305. PubMed ID: 35669785
[TBL] [Abstract][Full Text] [Related]
27. Antigen targeting to dendritic cells: Still a place in future immunotherapy?
Stoitzner P; Romani N; Rademacher C; Probst HC; Mahnke K
Eur J Immunol; 2022 Dec; 52(12):1909-1924. PubMed ID: 35598160
[TBL] [Abstract][Full Text] [Related]
28. Germinal center expansion but not plasmablast differentiation is proportional to peptide-MHCII density via CD40-CD40L signaling strength.
Jing Z; McCarron MJ; Dustin ML; Fooksman DR
Cell Rep; 2022 May; 39(5):110763. PubMed ID: 35508132
[TBL] [Abstract][Full Text] [Related]
29. STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells.
Sulczewski FB; Martino LA; da Silva Almeida B; Yamamoto MM; Rosa DS; Boscardin SB
Curr Res Immunol; 2021; 2():120-131. PubMed ID: 35492396
[TBL] [Abstract][Full Text] [Related]
30. Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation.
Guttman O; Le Thomas A; Marsters S; Lawrence DA; Gutgesell L; Zuazo-Gaztelu I; Harnoss JM; Haag SM; Murthy A; Strasser G; Modrusan Z; Wu T; Mellman I; Ashkenazi A
J Cell Biol; 2022 Jun; 221(6):. PubMed ID: 35446348
[TBL] [Abstract][Full Text] [Related]
31. ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection.
Arabpour M; Lebrero-Fernandez C; Schön K; Strömberg A; Börjesson V; Lahl K; Ballegeer M; Saelens X; Angeletti D; Agace W; Lycke N
Mucosal Immunol; 2022 Apr; 15(4):745-761. PubMed ID: 35418673
[TBL] [Abstract][Full Text] [Related]
32. Silent circulation of Chikungunya virus among pregnant women and newborns in the Western Brazilian Amazon before the first outbreak of chikungunya fever.
Kanunfre KA; Rocha MC; Malta MB; Souza RM; Castro MC; Boscardin SB; Souza HFS; Witkin SS; Cardoso MA; Okay TS
Rev Inst Med Trop Sao Paulo; 2022; 64():e25. PubMed ID: 35384956
[TBL] [Abstract][Full Text] [Related]
33. Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation.
Duan L; Liu D; Chen H; Mintz MA; Chou MY; Kotov DI; Xu Y; An J; Laidlaw BJ; Cyster JG
Immunity; 2021 Oct; 54(10):2256-2272.e6. PubMed ID: 34555336
[TBL] [Abstract][Full Text] [Related]
34. Antigen Delivery to DEC205
Silva MO; Almeida BS; Sales NS; Diniz MO; Aps LRMM; Rodrigues KB; Silva JR; Moreno ACR; Porchia BFMM; Sulczewski FB; Boscardin SB; Ferreira LCS
Int J Biol Sci; 2021; 17(11):2944-2956. PubMed ID: 34345218
[TBL] [Abstract][Full Text] [Related]
35. Fast antibody responses by immuno-targeting and nanotechnology strategies versus HBsAg vaccine.
Rezaei M; Hosseini SN; Khavari-Nejad RA; Najafi F; Mahdavi M
Iran J Basic Med Sci; 2021 Apr; 24(4):545-550. PubMed ID: 34094038
[TBL] [Abstract][Full Text] [Related]
36. Advances in Oral Subunit Vaccine Design.
Van der Weken H; Cox E; Devriendt B
Vaccines (Basel); 2020 Dec; 9(1):. PubMed ID: 33375151
[TBL] [Abstract][Full Text] [Related]
37. Live long and active: Polypeptide-mediated assembly of antibody variable fragments.
Lee C; Choi M; MacKay JA
Adv Drug Deliv Rev; 2020 Dec; 167():1-18. PubMed ID: 33129938
[TBL] [Abstract][Full Text] [Related]
38. Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1.
Pereira LR; Vicentin ECM; Pereira SA; Maeda DLNF; Alves RPDS; Andreata-Santos R; Sousa FTG; Yamamoto MM; Castro-Amarante MF; Favaro MTP; Romano CM; Sabino EC; Boscardin SB; Ferreira LCS
Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33019498
[TBL] [Abstract][Full Text] [Related]
39. Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection.
Jennewein MF; Mabuka J; Papia CL; Boudreau CM; Dong KL; Ackerman ME; Ndung'u T; Alter G
Front Immunol; 2020; 11():1744. PubMed ID: 32849622
[TBL] [Abstract][Full Text] [Related]
40. Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy.
Amon L; Hatscher L; Heger L; Dudziak D; Lehmann CHK
Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32674488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
